Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zignol

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2008
Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?I Dubrovina, K Miskinis, S Lyepshina, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 13, 2016
Use of Xpert(®) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in PakistanS Tahseen, E Qadeer, F M Khanzada, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 7, 2021
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-upO Oxlade, S den Boon, D Menzies, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Multidrug resistance in new tuberculosis patients: burden and implicationsS Royce, D Falzon, C van Weezenbeek, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevanceK M Kam, A Sloutsky, C W Yip, et al.
IJTLD Open|August 12, 2024
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19M Bastard, D Falzon, S Bertagnolio, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 17, 2019
Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden countryS Di Bella, A Siroka, R M Antonello, et al.
Public Health|September 5, 2020
Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018S Hargreaves, J Himmels, L B Nellums, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2011
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveysL Rigouts, A S Hoza, P De Rijk, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 27, 2009
The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural VietnamT N Buu, M N Huyen, N T N Lan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2008
Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?I Dubrovina, K Miskinis, S Lyepshina, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 13, 2016
Use of Xpert(®) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in PakistanS Tahseen, E Qadeer, F M Khanzada, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 7, 2021
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-upO Oxlade, S den Boon, D Menzies, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Multidrug resistance in new tuberculosis patients: burden and implicationsS Royce, D Falzon, C van Weezenbeek, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevanceK M Kam, A Sloutsky, C W Yip, et al.
IJTLD Open|August 12, 2024
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19M Bastard, D Falzon, S Bertagnolio, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 17, 2019
Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden countryS Di Bella, A Siroka, R M Antonello, et al.
Public Health|September 5, 2020
Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018S Hargreaves, J Himmels, L B Nellums, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2011
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveysL Rigouts, A S Hoza, P De Rijk, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 27, 2009
The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural VietnamT N Buu, M N Huyen, N T N Lan, et al.
Pageof 3